After having beaten established vaccine makers to produce the first Covid-19 shots, Moderna and BioNTech, with its partner Pfizer, are racing to dethrone them in another big market: flu.
在擊敗老牌疫苗生產商生產出首批新冠疫苗后，Moderna和BioNTech正與其合作伙伴輝瑞(Pfizer)競相在另一個大市場取代它們：流感。
您已閱讀2%（257字），剩余98%（11225字）包含更多重要信息，訂閱以繼續探索完整內容，并享受更多專屬服務。